Kissei Pharmaceutical Co Ltd
OTC:KSPHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kissei Pharmaceutical Co Ltd
OTC:KSPHF
|
JP |
|
Wilmington PLC
OTC:WMGTF
|
UK |
|
Parke Bancorp Inc
F:PAV
|
US |
|
M
|
Metro Mining Ltd
F:6ME
|
AU |
|
Xaar PLC
F:XAR
|
UK |
|
Ten Entertainment Group PLC
F:6YA
|
UK |
|
Pilot Energy Ltd
F:R8W
|
AU |
|
S
|
Sunbelt Rentals Holdings Inc
XHAM:C5X
|
US |
|
Rockcliff Metals Corp
F:RO0A
|
CA |
|
A
|
Artec Technologies AG
XMUN:A6T
|
DE |
Wall St Price Targets
KSPHF Price Targets Summary
Kissei Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for KSPHF is 30.15 USD with a low forecast of 23.99 USD and a high forecast of 36.48 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KSPHF's stock price target?
Price Target
30.15
USD
According to Wall Street analysts, the average 1-year price target for KSPHF is 30.15 USD with a low forecast of 23.99 USD and a high forecast of 36.48 USD.
What is the Revenue forecast for Kissei Pharmaceutical Co Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 2%.
What is the Gross Profit forecast for Kissei Pharmaceutical Co Ltd?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 2 years is 5%.
What is the Pre-Tax Income forecast for Kissei Pharmaceutical Co Ltd?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 6%. The projected CAGR for the next 2 years is -4%.
What is the Net Income forecast for Kissei Pharmaceutical Co Ltd?
Projected CAGR
-6%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 2 years is -6%.
